GENSCRIPT BIO
Biotechnology · Healthcare
CEO
1 appearance
Latest appearance 2026-08-17
CEO
GENSCRIPT BIO
Equibles does not estimate personal net worth.
Sherry Shaw is recorded as CEO at GENSCRIPT BIO. Sherry Shaw has spoken on 1 earnings call across 1 company, most recently for GENSCRIPT BIO on August 17, 2026. GENSCRIPT BIO is classified in the Biotechnology industry within the Healthcare sector.
“Before turning to company performance, I'd like to provide an overview of our company and the co-drivers behind our long-term growth. Gemscript is a leading global platform for lifetime services and products.”
GENSCRIPT BIO
CEO
Transcript header (unverified)
GENSCRIPT BIO
Biotechnology · Healthcare
CEO
2026 Interim Results Conference
GENSCRIPT BIO